FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

39933002: Pancreatic hormone (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
66522017 Pancreatic hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
776481015 Pancreatic hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
66522017 Pancreatic hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
66522017 Pancreatic hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
776481015 Pancreatic hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
776481015 Pancreatic hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

37 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pancreatic hormone Is a Hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Pancreatic hormone Is a Peptide hormones and their metabolites and precursors false Inferred relationship Existential restriction modifier (core metadata concept)
Pancreatic hormone Has disposition Pancreatic hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Pancreatic hormone Is a Peptide hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Pancreatic hormone Is a Substituted amide (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Gastrin-14 (substance) Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Gastrin, 17 residue fragment Is a False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Gastrin-34 Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Pancreatic peptide (substance) Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
C-peptide Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Gastrin II Is a False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Glucagon Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin Is a False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Gastrin-71 Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Non-suppressible insulin-like activity Is a False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Proinsulin Is a True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Big big gastrin Is a False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hormone radioassay - pancreas (procedure) Component True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept) 1
Human insulin analog product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing beef insulin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Pork insulin preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human insulin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing recombinant human insulin analog The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin glargine preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Rapid-acting insulin product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing intermediate-acting insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing long-acting insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing prompt zinc insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing pancreatic hormone (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing short-acting insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human insulin 100units/mL injection cartridge (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human insulin 100iu/mL injection vial (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin lispro 100iu/mL injection vial (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin lispro 100units/mL injection 3mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
insuline lispro 100 unités/mL, stylo prérempli de 3 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin zinc suspension bovine 100u/mL injection suspension 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
insuline zinc en suspension (humaine), 100 unités/mL, flacon de 10 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin zinc crystalline human suspension 100units/mL injection vial (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane human 100units/mL injection 3mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human isophane insulin 100units/mL injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
insuline-protamine-zinc bovine, 100 unités/mL, flacon de 10 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human insulin 100units/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human isophane insulin 100units/mL prefilled pen (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin soluble bovine 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin soluble bovine 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane bovine 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin soluble porcine 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin soluble porcine 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane porcine 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic lispro 25/75 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic lispro 50/50 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 10/90 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 20/80 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 20/80 100units/mL injection 3mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 20/80 100units/mL injection 3mL prefilled pen (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 30/70 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 30/70 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 40/60 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 50/50 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 50/50 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 50/50 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 15/85 100units/mL injection 5mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane human 25/75 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic lispro 25/75 100units/mL injection 3mL cartridge(product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin soluble human 100units/mL injection 5mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin soluble human 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin lispro 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane human 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane human 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane porcine 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane porcine 30/70 100units/mL injection 10mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic isophane porcine 30/70 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin zinc suspension bovine and porcine 100units/mL injection 10mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin glargine 100unt/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin human 30% w/v insulin susp isophane recomb 70% injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing insulin aspart (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin lispro-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human isophane insulin 100units/mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 30/70 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 30/70 100units/ml injection 1.5ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 25/75 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane porcine 100units/ml injection 1.5ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pancreatic hormone Inferred relationship Existential restriction modifier (core metadata concept)

Page 1 of 2 End

This concept is not in any reference sets

Back to Start